BIOG
NEUTRALThe Biotech Growth Trust PLC Announces Director Appointment
The asset manager has announced the appointment of a non-executive director to the board of another company, effective January 1, 2026.
The Biotech Growth Trust
1,227.59GBX
1.04%
Market Cap
260.21M
Volume
40.86k
41% of avg
P/E Ratio
NaN
EPS (TTM)
Beta
0.34
Day Range
1,210.00p - 1,230.00p
52 Week Range
612.70p1,227.59p1,295.00p
1,227.59p
Upcoming Events
BIOG
GOODBiotech Growth Trust Reports Strong Half-Year Performance with 36.9% NAV Return
This investment trust reported a stellar 36.9% NAV return, outperforming its benchmark. Strong stock selection and increased gearing contributed to the impressive results, positioning the fund well for future growth in the dynamic biotech sector.
BIOG
NEUTRALThe Biotech Growth Trust PLC Releases Monthly Fact Sheet
The asset management firm has published its monthly fact sheet for The Biotech Growth Trust PLC.
BIOG
NEUTRALThe Biotech Growth Trust PLC Confirms Compliance with Market Abuse Regulation
The investment trust confirms it has complied with market abuse regulations, providing no material updates on its financial position or outlook.
BIOG
NEUTRALThe Biotech Growth Trust PLC Announces Director/PDMR Shareholding
The prominent investment trust has announced a change in its non-executive director's shareholding.
BIOG
NEUTRALThe Biotech Growth Trust PLC Announces Investor Presentation
The prominent investment trust is hosting an investor presentation via Investor Meet Company.
BIOG
NEUTRALThe Biotech Growth Trust PLC Publishes Monthly Fact Sheet
The asset management firm has released its monthly fact sheet, providing an update on the performance of its biotechnology-focused investment trust.
BIOG
BADThe Biotech Growth Trust Provides Investor Webinar Update
The prominent biotech investment trust announces an investor webinar, but the tone of the update suggests the company is facing a challenging operating environment.
BIOG
BADThe Biotech Growth Trust Appoints New Director with Public Health Expertise
The prominent biotech investment trust has appointed a new director with extensive public health leadership experience, as the company navigates the integration of multiple agencies into a unified health security organization.
BIOG
NEUTRALThe Biotech Growth Trust PLC Publishes Monthly Fact Sheet
The prominent investment trust has released its monthly fact sheet, providing an update on its portfolio and activities.